Drop in prescriptions for antibiotic leads to fewer cases of superbug in Wales
pharmafile | August 20, 2019 | News story | Manufacturing and Production | AMR, Antibiotics, C difficile, C. difficile, pharma, superbug
Cuts to the number of prescriptions for antibiotics have led to a drop in the number of cases of the superbug C. difficile, an NHS health board has said.
The Betsi Cadwaladr health board, the largest health organisation in Wales, said prescriptions for antibiotics fell by 12.6 from 2017-2018 to 2018-2019. Wales hope to cut the number of antibiotic prescriptions by 5%.
The cutback saw the number of cases of C. difficile fall from 271 in 2017-18 to 166 cases in 2018-19.
Pauline Roberts, Betsi Cadwaladr’s primary care pharmacist, said: “Everyone understands we have a problem nationally with the overuse of antibiotics, but it’s hard to change without the tools to improve the way we deliver care.
“We’ve tried to work with GP practices to give them resources to support this work, and supporting them by educating patients that antibiotics don’t work against viruses.”
The measures have seen far reaching cuts in prescriptions for antibiotics over the past few years.
Louis Goss
Related Content
Acurx Pharmaceuticals announces positive data from phase 2b trial for C. difficile infection treatment
Acurx Pharmaceuticals has announced that it has discontinued its phase 2b clinical trial of its …
BactiVac funds development of bacterial vaccines to prevent infections against antimicrobial resistance
The University of Birmingham hosted Bacterial Vaccines Network has been awarded £1.4m in funding from …
FDA approves IMIDEX’s AI-powered device VisiRad XR
The technological pharmaceutical company IMIDEX has been granted clearance from the US Food and Drug …